{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:26:25Z","timestamp":1790400385380,"version":"4.1.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"DOI":"10.1210\/jc.2010-0220","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T22:12:47Z","timestamp":1274307167000},"page":"3863-3870","source":"Crossref","is-referenced-by-count":58,"title":["Proteomic Analysis of Plasma in the Polycystic Ovary Syndrome Identifies Novel Markers Involved in Iron Metabolism, Acute-Phase Response, and Inflammation"],"prefix":"10.1210","volume":"95","author":[{"given":"Mari\u0301a","family":"Insenser","sequence":"first","affiliation":[{"name":"Departments of Endocrinology (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.) Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain;"},{"name":"Centro de Investigaciones Biome\u0301dicas en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A\u0301ngeles","family":"Marti\u0301nez-Garci\u0301a","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.) Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain;"},{"name":"Centro de Investigaciones Biome\u0301dicas en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Montes","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.) Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain;"},{"name":"Centro de Investigaciones Biome\u0301dicas en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301 L.","family":"San-Milla\u0301n","sequence":"additional","affiliation":[{"name":"Departments of Molecular Genetics (J.L.S.-M.), Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He\u0301ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.) Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain;"},{"name":"Centro de Investigaciones Biome\u0301dicas en Red de Diabetes y Enfermedades Metabo\u0301licas Asociadas (M.I., M. A\u0301.M.-G., R.M., H.F.E.-M.), Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114000446100_R1","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncio\u0301n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114000446100_R2","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114000446100_R3","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114000446100_R4","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041114000446100_R5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114000446100_R6","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041114000446100_R7","first-page":"49","article-title":"Insulin resistance, obesity and metabolic syndrome in polycystic ovary syndrome","volume":"53","author":"Gambineri","year":"2006","journal-title":"Endocrinol Nutr"},{"key":"key\n\t\t\t\t2019041114000446100_R8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114000446100_R9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","article-title":"Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease.","volume":"34","author":"Sabuncu","year":"2001","journal-title":"Clin Biochem"},{"key":"key\n\t\t\t\t2019041114000446100_R10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114000446100_R11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mob.2002.119180","article-title":"Polycystic ovary syndrome: a risk for coronary artery disease?","volume":"186","author":"Wild","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041114000446100_R12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114000446100_R13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/jc.2005-2501","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.","volume":"91","author":"Franks","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114000446100_R14","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: toward a rational approach","author":"Zawadzki","year":"1992","journal-title":"In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;"},{"key":"key\n\t\t\t\t2019041114000446100_R15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114000446100_R16","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114000446100_R17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114000446100_R18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/humupd\/dmn024","article-title":"Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response.","volume":"14","author":"Simoni","year":"2008","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t2019041114000446100_R19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1471-0528.2008.02041.x","article-title":"Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review.","volume":"116","author":"Atiomo","year":"2009","journal-title":"BJOG"},{"key":"key\n\t\t\t\t2019041114000446100_R20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114000446100_R21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/dc09-0420","article-title":"Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance and genomic variants related to inflammation, oxidative stress and iron metabolism.","volume":"32","author":"Marti\u0301nez-Garci\u0301a","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114000446100_R22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114000446100_R23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/elps.1150080203","article-title":"Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels.","volume":"8","author":"Blum","year":"1987","journal-title":"Electrophoresis"},{"key":"key\n\t\t\t\t2019041114000446100_R24","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/pmic.200300681","article-title":"Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis.","volume":"4","author":"Karp","year":"2004","journal-title":"Proteomics"},{"key":"key\n\t\t\t\t2019041114000446100_R25","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00216-005-3126-3","article-title":"The development of the DIGE system: 2D fluorescence difference gel analysis technology.","volume":"382","author":"Marouga","year":"2005","journal-title":"Anal Bioanal Chem"},{"key":"key\n\t\t\t\t2019041114000446100_R26","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1021\/ac9806005","article-title":"Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification.","volume":"70","author":"Sechi","year":"1998","journal-title":"Anal Chem"},{"key":"key\n\t\t\t\t2019041114000446100_R27","first-page":"159","article-title":"Haptoglobin","author":"Bowman","year":"1993","journal-title":"In: Bowman BH, ed. Hepatic plasma proteins. San Diego: Academic Press;"},{"key":"key\n\t\t\t\t2019041114000446100_R28","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/pmic.200300830","article-title":"SWISS-2DPAGE, ten years later.","volume":"4","author":"Hoogland","year":"2004","journal-title":"Proteomics"},{"key":"key\n\t\t\t\t2019041114000446100_R29","doi-asserted-by":"crossref","first-page":"e5606","DOI":"10.1371\/journal.pone.0005606","article-title":"Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women","volume":"4","author":"Alvarez-Blasco","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019041114000446100_R30","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1021\/pr070124b","article-title":"Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms.","volume":"6","author":"Matharoo-Ball","year":"2007","journal-title":"J Proteome Res"},{"key":"key\n\t\t\t\t2019041114000446100_R31","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","article-title":"Proteome-based plasma biomarkers for Alzheimer\u2019s disease.","volume":"129","author":"Hye","year":"2006","journal-title":"Brain"},{"key":"key\n\t\t\t\t2019041114000446100_R32","first-page":"511","article-title":"Disorders of iron metabolism","author":"Beutler","year":"2006","journal-title":"In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, eds. Williams hematology. 7th ed. New York: McGraw-Hill;"},{"key":"key\n\t\t\t\t2019041114000446100_R33","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114000446100_R34","first-page":"71","article-title":"Two-dimensional difference gel electrophoresis.","volume":"328","author":"Wu","year":"2006","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t2019041114000446100_R35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humrep\/dem380","article-title":"Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry.","volume":"23","author":"Corto\u0301n","year":"2008","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t2019041114000446100_R36","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2337\/diabetes.51.8.2348","article-title":"Cross-talk between iron metabolism and diabetes.","volume":"51","author":"Ferna\u0301ndez-Real","year":"2002","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114000446100_R37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2002-0010","article-title":"Insulin resistance and chronic cardiovascular inflammatory syndrome.","volume":"24","author":"Ferna\u0301ndez-Real","year":"2003","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114000446100_R38","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/diacare.28.8.2042","article-title":"Body iron stores are increased in overweight and obese women with polycystic ovary syndrome.","volume":"28","author":"Escobar-Morreale","year":"2005","journal-title":"Diabetes Care"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/8\/3863\/9068593\/jcem3863.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:21:19Z","timestamp":1559107279000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/8\/3863\/2597079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0220","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,1]]}}}